Production of Antibiotics

Penicillium chrysogenum is a filamentous fungus naturally capable of producing penicillin, one of the earliest and most widely used antibiotics. Industrial strains have undergone extensive strain-improvement programs using UV irradiation and chemical mutagens to produce significantly higher penicillin titers than wild-type counterparts, making them economically viable for large-scale production.

Carbon catabolite repression occurs when high glucose concentrations suppress penicillin synthesis. To prevent this, lactose is used as the initial carbon source because it is metabolized slowly and does not trigger rapid biomass accumulation. Glucose is added later in minimal quantities to support growth without inhibiting antibiotic production.

Initially, fungal cells multiply exponentially during the growth phase with minimal penicillin synthesis. As carbon sources become depleted, the culture enters stationary phase and begins producing penicillin, a secondary metabolite. This phase shift is critical because penicillin synthesis is promoted when vegetative growth slows, allowing metabolic resources to redirect toward antibiotic production.

Large stirred-tank bioreactors maintain tightly controlled temperature between 25 to 27 °C and pH between 6.8 to 7.4 to support fungal metabolism and maximize antibiotic yield. These conditions, along with controlled dissolved oxygen levels, are essential for optimizing the bioreactor design and operational system that supports consistent penicillin production.

Phenylacetic acid is added as a side-chain precursor to direct the synthesis of penicillin G, a specific penicillin variant. It is fed gradually into the fermenter at controlled rates because excessive concentrations can inhibit fungal growth, making precise feeding strategy essential for maximizing both growth and antibiotic yield.

After approximately one week of fermentation, the broth is filtered and purified to collect penicillin. The extracted penicillin is then converted into 6-aminopenicillanic acid (6-APA), the core molecule used to synthesize a variety of semisynthetic penicillins with improved stability, broader activity spectra, and enhanced pharmacological properties through downstream processing.

Nitrogen limitation is a key nutritional strategy to restrict vegetative growth and promote secondary metabolism. By controlling nitrogen availability alongside careful carbon source management, the culture is redirected toward antibiotic production rather than fungal biomass accumulation, enhancing the overall penicillin yield from the fermentation process.